FI932105A - Sulfonylbensylsubstituerade benso- och pyridopyridoner - Google Patents

Sulfonylbensylsubstituerade benso- och pyridopyridoner Download PDF

Info

Publication number
FI932105A
FI932105A FI932105A FI932105A FI932105A FI 932105 A FI932105 A FI 932105A FI 932105 A FI932105 A FI 932105A FI 932105 A FI932105 A FI 932105A FI 932105 A FI932105 A FI 932105A
Authority
FI
Finland
Prior art keywords
sulfonylbenyl
pyridopyridoner
benso
substitutes
och
Prior art date
Application number
FI932105A
Other languages
English (en)
Other versions
FI932105A0 (fi
Inventor
Juergen Dressel
Peter Fey
Rudolf H Hanko
Walter Huebsch
Thomas Kraemer
Ulrich E Mueller
Matthias Mueller-Gliemann
Martin Beuck
Stanislav Kazda
Stefan Wohlfeil
Andreas Knorr
Johannes-Peter Stasch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI932105A0 publication Critical patent/FI932105A0/fi
Publication of FI932105A publication Critical patent/FI932105A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
FI932105A 1992-05-12 1993-05-10 Sulfonylbensylsubstituerade benso- och pyridopyridoner FI932105A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4215587A DE4215587A1 (de) 1992-05-12 1992-05-12 Sulfonylbenzyl-substituierte Benzo- und Pyridopyridone

Publications (2)

Publication Number Publication Date
FI932105A0 FI932105A0 (fi) 1993-05-10
FI932105A true FI932105A (fi) 1993-11-13

Family

ID=6458654

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932105A FI932105A (fi) 1992-05-12 1993-05-10 Sulfonylbensylsubstituerade benso- och pyridopyridoner

Country Status (21)

Country Link
US (1) US5354749A (fi)
EP (1) EP0569795B1 (fi)
JP (1) JPH0649031A (fi)
KR (1) KR930023362A (fi)
CN (1) CN1080923A (fi)
AT (1) ATE121086T1 (fi)
AU (1) AU3710693A (fi)
CA (1) CA2095801A1 (fi)
CZ (1) CZ72393A3 (fi)
DE (2) DE4215587A1 (fi)
DK (1) DK0569795T3 (fi)
ES (1) ES2072784T3 (fi)
FI (1) FI932105A (fi)
GR (1) GR3015836T3 (fi)
HU (1) HU9301366D0 (fi)
IL (1) IL105646A0 (fi)
MX (1) MX9302461A (fi)
NO (1) NO931534L (fi)
PL (1) PL298890A1 (fi)
SK (1) SK46693A3 (fi)
ZA (1) ZA933273B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4301900A1 (de) * 1993-01-25 1994-07-28 Bayer Ag 2-Oxochinolin-1-yl-methylphenylessigsäurederivate
TW263498B (fi) * 1993-11-10 1995-11-21 Takeda Pharm Industry Co Ltd
WO2006045010A2 (en) * 2004-10-20 2006-04-27 Resverlogix Corp. Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
AU2006275514B2 (en) 2005-07-29 2012-04-05 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
CA2676984C (en) 2007-02-01 2015-03-17 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular diseases
US8114995B2 (en) 2008-06-26 2012-02-14 Resverlogix Corp. Methods of preparing quinazolinone derivatives
SG172785A1 (en) 2008-12-23 2011-08-29 Hoffmann La Roche Dihydropyridone amides as p2x7 modulators
KR101381074B1 (ko) 2008-12-23 2014-04-11 에프. 호프만-라 로슈 아게 Ｐ2ｘ7 조절제로서의 디히드로피리돈 아미드
US8153808B2 (en) 2008-12-23 2012-04-10 Roche Palo Alto Llc Dihydropyridone amides as P2X7 modulators
CA2745866A1 (en) 2008-12-23 2010-07-01 F.Hoffmann-La Roche Ag Dihydropyridone ureas as p2x7 modulators
CN102264722B (zh) 2008-12-23 2014-04-02 霍夫曼-拉罗奇有限公司 作为p2x7调节剂的二氢吡啶酮酰胺
ES2542835T3 (es) 2009-01-08 2015-08-12 Resverlogix Corporation Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
JP5795304B2 (ja) 2009-03-18 2015-10-14 レスバーロジックス コーポレイション 新規抗炎症剤
KR101892987B1 (ko) 2009-04-22 2018-08-30 리스버로직스 코퍼레이션 신규한 소염제
CA2851996C (en) 2011-11-01 2020-01-07 Resverlogix Corp. Pharmaceutical compositions for substituted quinazolinones
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
EP2935253B1 (en) 2012-12-21 2018-08-01 Zenith Epigenetics Ltd. Novel heterocyclic compounds as bromodomain inhibitors
CA2977308A1 (en) 2015-03-13 2016-09-22 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
CN110327347B (zh) * 2019-08-16 2021-06-01 陕西科技大学 G-749在制备抗真菌药物中的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2314985A1 (de) * 1973-03-26 1974-10-17 Hoechst Ag 1-(imidazol-1-yl)-isochinoline und verfahren zu ihrer herstellung
JPS6145820A (ja) * 1984-03-07 1986-03-05 Nippon Piston Ring Co Ltd 粉末成形体の定間隔整列方法及びその整列装置
DE3800785A1 (de) * 1988-01-09 1989-07-20 Hoechst Ag Substituierte 7-(pyridazin-5-yl)-3,5-dihydroxyheptan(en)- saeuren, ihre entsprechenden (delta)-lactone bzw. derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
GB8911854D0 (en) * 1989-05-23 1989-07-12 Ici Plc Heterocyclic compounds
IE64514B1 (en) * 1989-05-23 1995-08-09 Zeneca Ltd Azaindenes
DE10075018I2 (de) * 1989-06-14 2001-08-09 Smithkline Beecham Corp Imidazoalkensäure.
EP0403158A3 (en) * 1989-06-14 1991-12-18 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
US5164407A (en) * 1989-07-03 1992-11-17 Merck & Co., Inc. Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists
WO1991001001A1 (en) * 1989-07-06 1991-01-24 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland A detector for monitoring low molecular weight compounds
BG92674A (bg) * 1989-08-11 1993-12-24 David Roberts Метод за получаване на производни на хинолина
AU640417B2 (en) * 1989-10-25 1993-08-26 Smithkline Beecham Corporation Substituted 5-((tetrazolyl)alkenyl)imidazoles
JP2860676B2 (ja) * 1989-12-07 1999-02-24 川研ファインケミカル株式会社 １―イソキノリン類の製造方法
GB9010394D0 (en) * 1990-05-09 1990-06-27 Ici Plc Heterocyclic compounds
IL99246A0 (en) * 1990-09-10 1992-07-15 Abbott Lab Angiotensin ii receptor antagonists and pharmaceutical compositions containing them
GB9025123D0 (en) * 1990-11-19 1991-01-02 Ici Plc Nitrogen compounds
US5162325A (en) * 1991-05-07 1992-11-10 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted benzyl element
US5162340A (en) * 1991-05-10 1992-11-10 Merck & Co., Inc. Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists
US5256667A (en) * 1991-09-25 1993-10-26 Merck & Co., Inc. Quinazolinones and pyridopyrimidinones
DE4206045A1 (de) * 1992-02-27 1993-09-02 Bayer Ag Sulfonylbenzyl substituierte pyridone

Also Published As

Publication number Publication date
HU9301366D0 (en) 1993-09-28
ATE121086T1 (de) 1995-04-15
DK0569795T3 (da) 1995-08-28
GR3015836T3 (en) 1995-07-31
ES2072784T3 (es) 1995-07-16
FI932105A0 (fi) 1993-05-10
EP0569795B1 (de) 1995-04-12
DE4215587A1 (de) 1993-11-18
MX9302461A (es) 1994-06-30
NO931534D0 (no) 1993-04-27
CA2095801A1 (en) 1993-11-13
AU3710693A (en) 1993-11-18
SK46693A3 (en) 1994-02-02
NO931534L (no) 1993-11-15
CN1080923A (zh) 1994-01-19
US5354749A (en) 1994-10-11
JPH0649031A (ja) 1994-02-22
PL298890A1 (en) 1994-01-10
IL105646A0 (en) 1993-09-22
ZA933273B (en) 1993-11-29
KR930023362A (ko) 1993-12-18
CZ72393A3 (en) 1993-12-15
DE59300135D1 (de) 1995-05-18
EP0569795A1 (de) 1993-11-18

Similar Documents

Publication Publication Date Title
FI932105A (fi) Sulfonylbensylsubstituerade benso- och pyridopyridoner
FI942160A0 (fi) Substituoituja mono- ja bipyridyylimetyylipyridoneja
ES2082872T3 (es) Composiciones antiglaucoma que contienen 3-arilcarbonil-1-aminoalquil--1h-indol.
NZ248794A (en) 3-carboxy-(and phosphonoxy-)alkatriene-substituted chromene derivatives and medicaments
DE59401990D1 (de) Imidazolyl-substituierte Phenylessigsäureprolinamide
DK0617035T3 (da) Hetero-tricyclisk-substituerede phenyl-cyclohexan-carboxylsyrederivater.
ES2123728T3 (es) Derivados de pirrolo-pirazina de actividad 5-ht3.
DE59310098D1 (de) Imidazolyl-substituierte Cyclohexanderivate
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments
IE791438L (en) Oxadiazolotriazines

Legal Events

Date Code Title Description
FD Application lapsed